[Form 4] Innovex International, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Innovex International insider sale from tax-withheld restricted stock units. Innovex CFO Kendal Reed reported a disposition of 3,033 shares of Innovex common stock on 09/08/2025 at a price of $16.82 per share. The filing states the shares were withheld to satisfy tax withholding obligations upon release of restricted stock units. After the withholding, the reporting person beneficially owns 208,726 shares directly. The Form 4 was signed by an attorney-in-fact on 09/10/2025. The filing identifies the reporting person as Chief Financial Officer and provides a Houston, TX mailing address.

Insights

Financial Analyst

TL;DR: Routine tax-withholding share disposition by CFO; non-cash event that modestly reduces outstanding personal holdings.

This Form 4 documents a common practice where restricted stock units vest and the company withholds shares to cover taxes rather than the insider selling shares on the open market. The disposition of 3,033 shares at $16.82 each reduces Kendal Reed's direct holdings to 208,726 shares. There is no indication of additional open-market selling or acquisition, and the transaction is described solely as tax withholding related to RSU release, which is typically non-material to the issuer.

Corporate Governance Expert

TL;DR: Proper disclosure of RSU withholding; filing appears compliant and routine.

The Form 4 identifies the reporting persons role as Chief Financial Officer and discloses the withholding action transparently. The signature by an attorney-in-fact is provided and the transaction date and post-transaction beneficial ownership are reported. This matches standard Section 16 reporting for equity compensation settlements and does not, by itself, raise governance concerns.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Reed Kendal

(Last) (First) (Middle)

C/O INNOVEX INTERNATIONAL, INC.

19120 KENSWICK DRIVE

(Street)

HUMBLE TX 77338

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Innovex International, Inc. [ INVX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
09/08/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	09/08/2025		F		3,033(1)	D	$16.82	208,726	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The Shares are withheld at the election of the Reporting Person to satisfy tax withholding obligations with the release of restricted stock units.

	/s/ Matt Steinheider, Attorney-in-Fact for Kendal Reed	09/10/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Innovex (INVX) CFO Kendal Reed report on Form 4?

The report discloses a disposition of 3,033 shares on 09/08/2025 at a reported price of $16.82 per share.

Why were the 3,033 shares disposed according to the Form 4?

The filing states the shares were withheld to satisfy tax withholding obligations upon release of restricted stock units.

How many Innovex shares does Kendal Reed beneficially own after the reported transaction?

The Form 4 reports 208,726 shares beneficially owned following the transaction.

When was the Form 4 signed and by whom?

The Form 4 is signed by Matt Steinheider, Attorney-in-Fact for Kendal Reed on 09/10/2025.

What is Kendal Reed's relationship to Innovex reported on the Form 4?

Kendal Reed is reported as an Officer with the title Chief Financial Officer.